Oracle adds analytics to boost clinical trial efficiency

By Nick Taylor

- Last updated on GMT

Related tags: Clinical trial

Oracle Health Sciences has strengthened its clinical trial analytics offering to reduce start up times and offer greater insight into screening, recruitment and retention.

Biopharm is under pressure to perform clinical trials more efficiently. To support these efforts Oracle has been organically and inorganically strengthening its life science software suite, most recently with the introduction of Clinical Development Analytics 2.0 and Data Hub 2.1.4.

Life sciences organisations are increasingly focused on improving operational efficiency and productivity across the discovery and development phases to improve the overall performance of their programmes​”, said Neil de Crescenzo, senior vice president, Oracle Health Sciences.

Introduction of Clinical Development Analytics 2.0 builds on the software’s original focus on data management to provide rich content for clinical operations. The software includes more than 360 pre-built and pre-sourced metrics to provide insight into trial performance.

Oracle claims the software helps: boost trial efficiency by giving insight into screening, recruitment and retention; identify bottlenecks at low performing sites and regions; detect barriers to cut start up times; and accelerate database lock.

Data used by the analytics software is sourced directly from Oracle’s Siebel Clinical Trial Management System, as well as the company’s Clinical and Remote Data Capture packages.

Data Hub

Launch of Clinical Development Analytics 2.0 was accompanied by introduction of Data Hub 2.1.4. Using Data Hub 2.1.4 biopharm can integrate clinical, non-clinical and safety data from multiple sources into a single, validated and secure repository.

Collating data into a single repository helps biopharm streamline business processes related to the acquisition, analysis and reporting of clinical trial data. Biopharm can use the platform to increase research efficiency, simplify regulatory compliance and inform decision making.

Oracle claims version 2.1.4: boosts productivity by improving usability, for instance by simplifying submission processes; expands business intelligence capabilities to provide greater insight; and streamlines data integration.

Related news

Show more

Related products

show more

How a clinical metadata repository helps with data

How a clinical metadata repository helps with data

Formedix | 22-Mar-2021 | Technical / White Paper

This article covers the various ways a clinical metadata repository helps with data quality, and in turn, with data quality in the clinical trials process....

Introduction to eLAS®

Introduction to eLAS®

Clinical Ink | 08-Mar-2021 | Product Brochure

Clinical Ink has developed a unique offering — the electronic Lupus Assessment Suite (eLAS®) to address fundamental challenges impacting systemic lupus...

Related suppliers

Follow us


View more